Jefferies analysts recently upgraded their rating on GE HealthCare (NASDAQ:GEHC) Technologies Inc. to "buy" from "hold," ...

Sheila Kahyaoglu, Jefferies aerospace and defense analyst, joins CNBC's The Exchange to discuss why her firm increased the ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...

Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...

Jefferies analyst Julien Dumoulin Smith reiterated a Buy rating on GE Vernova Inc. (GEV – Research Report) yesterday and set a price target of ...

Attractive total yields and much cleaner positioning are among the reasons investors should consider reinstating long positions in credit, Jefferies said.

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

The outlook for India's auto industry in 2025 shows signs of divergence in growth among key sectors, with two-wheelers and ...

Anand Rathi believes multiple players can co-exist in the quick commerce space. It initiated coverage on Zomato and Swiggy ...